• 1
    Hayles J,Beach D,Durkacz B,Nurse P. The fission yeast cell cycle control gene cdc2: isolation of a sequence suc1 that suppresses cdc2 mutant function. Mol Gen Genet 1986; 202: 2913.
  • 2
    Richardson HE,Stueland CS,Thomas J,Russell P,Reed SI. Human cDNAs encoding homologs of the small p34Cdc28/Cdc2-associated protein of Saccharomyces cerevisiae and Schizosaccharomyces pombe. Genes Dev 1990; 4: 133244.
  • 3
    Hadwiger JA,Wittenberg C,Mendenhall MD,Reed SI. The Saccharomyces cerevisiae CKS1 gene, a homolog of the Schizosaccharomyces pombe suc1+ gene, encodes a subunit of the Cdc28 protein kinase complex. Mol Cell Biol 1989; 9: 203441.
  • 4
    Spruck C,Strohmaier H,Watson M,Smith AP,Ryan A,Krek TW,Reed SI. A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1. Mol Cell 2001; 7: 63950.
  • 5
    Ganoth D,Bornstein G,Ko TK,Larsen B,Tyers M,Pagano M,Hershko A. The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27. Nat Cell Biol 2001; 3: 3214.
  • 6
    Urbanowicz-Kachnowicz I,Baghdassarian N,Nakache C,Gracia D,Mekki Y,Bryon PA,Ffrench M. ckshs expression is linked to cell proliferation in normal and malignant human lymphoid cells. Int J Canc 1999; 82: 98104.
  • 7
    Spruck CH,de Miguel MP,Smith AP,Ryan A,Stein P,Schultz RM,Lincoln AJ,Donovan PJ,Reed SI. Requirement of Cks2 for the first metaphase/anaphase transition of mammalian meiosis. Science 2003; 300: 64750.
  • 8
    Kawakami K,Enokida H,Tachiwada T,Gotanda T,Tsuneyoshi K,Kubo H,Nishiyama K,Takiguchi M,Nakagawa M,Seki N. Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling. Oncol Rep 2006; 16: 52131.
  • 9
    Wong YF,Cheung TH,Tsao GS,Lo KW,Yim SF,Wang VW,Heung MM,Chan SC,Chan LK,Ho TW,Wong KW,Li C, et al. Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray. Int J Canc 2006; 118: 24619.
  • 10
    Chow LS,Lam CW,Chan SY,Tsao SW,To KF,Tong SF,Hung WK,Dammann R,Huang DP,Lo KW. Identification of RASSF1A modulated genes in nasopharyngeal carcinoma. Oncogene 2006; 25: 31016.
  • 11
    de Wit NJ,Rijntjes J,Diepstra JH,van Kuppevelt TH,Weidle UH,Ruiter DJ,van Muijen GN. Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays. Br J Canc 2005; 92: 224961.
  • 12
    Zirn B,Samans B,Spangenberg C,Graf N,Eilers M,Gessler M. All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo. Oncogene 2005; 24: 524651.
  • 13
    Lin CY,Strom A,Kong SL,Kietz S,Thomsen JS,Tee JB,Vega VB,Miller LD,Smeds J,Bergh J,Gustafsson JA,Liu ET. Inhibitory effects of estrogen receptor beta on specific hormone responsive gene expression and association with disease outcome in primary breast cancer. Breast Canc Res 2007; 9: R25.
  • 14
    Uchikado Y,Inoue H,Haraguchi N,Mimori K,Natsugoe S,Okumura H,Aikou T,Mori M. Gene expression profiling of lymph node metastasis by oligomicroarray analysis using laser microdissection in esophageal squamous cell carcinoma. Int J Oncol 2006; 29: 133747.
  • 15
    Rother K,Dengl M,Lorenz J,Tschop K,Kirschner R,Mossner J,Engeland K. Gene expression of cyclin-dependent kinase subunit Cks2 is repressed by the tumor suppressor p53 but not by the related proteins p63 or p73. FEBS Lett 2007; 581: 116672.
  • 16
    Kudo Y,Kitajima S,Ogawa I,Miyauchi M,Takata T. Down-regulation of Cdk inhibitor p27 in oral squamous cell carcinoma. Oral Oncol 2005; 41: 10516.
  • 17
    Ouellet V,Provencher DM,Maugard CM,Le Page C,Ren F,Lussier C,Novak J,Ge B,Hudson TJ,Tonin PN,Mes-Masson AM. Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling. Oncogene 2005; 24: 467287.
  • 18
    Shapira M,Ben-Izhak O,Linn S,Futerman B,Minkov I,Hershko DD. The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma. Cancer 2005; 103: 133646.
  • 19
    Slotky M,Shapira M,Ben-Izhak O,Linn S,Futerman B,Tsalic M,Hershko DD. The expression of the ubiquitin ligase subunit Cks1 in human breast cancer. Breast Canc Res 2005; 7: R73744.
  • 20
    Ouellet V,Guyot MC,Le Page C,Filali-Mouhim A,Lussier C,Tonin PN,Provencher DM,Mes-Masson AM. Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer. Int J Canc 2006; 119: 599607.
  • 21
    Li SH,Li CF,Sung MT,Eng HL,Hsiung CY,Huang WW,Lin CN,Yu SC,Huang HY. Skp2 is an independent prognosticator of gallbladder carcinoma among p27(Kip1)-interacting cell cycle regulators: an immunohistochemical study of 62 cases by tissue microarray. Mod Pathol 2007; 20: 497507.
  • 22
    Hershko DD,Shapira M. Prognostic role of p27Kip1 deregulation in colorectal cancer. Cancer 2006; 107: 66875.
  • 23
    Kitajima S,Kudo Y,Ogawa I,Bashir T,Kitagawa M,Miyauchi M,Pagano M,Takata T. Role of Cks1 overexpression in oral squamous cell carcinomas: cooperation with Skp2 in promoting p27 degradation. Am J Pathol 2004; 165: 214755.
  • 24
    Zhang Y,Lin Y,Bowles C,Wang F. Direct Cell Cycle Regulation by the Fibroblast Growth Factor Receptor (FGFR) Kinase through Phosphorylation-dependent Release of Cks1 from FGFR Substrate 2. J Biol Chem 2004; 279: 5534854.
  • 25
    Shapira M,Ben-Izhak O,Slotky M,Goldin O,Lahav-Baratz S,Hershko DD. Expression of the ubiquitin ligase subunit cyclin kinase subunit 1 and its relationship to S-phase kinase protein 2 and p27Kip1 in prostate cancer. J Urol 2006; 176: 22859.
  • 26
    Lu X,Guo J,Hsieh TC. PC-SPES inhibits cell proliferation by modulating p21, cyclins D. E and. B and multiple cell cycle-related genes in prostate cancer cells. Cell Cycle 2003; 2: 5963.
  • 27
    Jin C,McKeehan K,Guo W,Jauma S,Ittmann MM,Foster B,Greenberg NM,McKeehan WL,Wang F. Cooperation between ectopic FGFR1 and depression of FGFR2 in induction of prostatic intraepithelial neoplasia in the mouse prostate. Canc Res 2003; 63: 878490.
  • 28
    Kaplan-Lefko PJ,Chen TM,Ittmann MM,Barrios RJ,Ayala GE,Huss WJ,Maddison LA,Foster BA,Greenberg NM. Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate 2003; 55: 21937.
  • 29
    Lin Y,Liu G,Zhang Y,Hu YP,Yu K,Lin C,McKeehan K,Xuan JW,Ornitz DM,Shen MM,Greenberg N,McKeehan WL, et al. Fibroblast growth factor receptor 2 tyrosine kinase is required for prostatic morphogenesis and the acquisition of strict androgen dependency for adult tissue homeostasis. Development 2007; 134: 72334.
  • 30
    Wu X,Jin C,Wang F,Yu C,McKeehan WL. Stromal cell heterogeneity in fibroblast growth factor-mediated stromal-epithelial cell cross-talk in premalignant prostate tumors. Canc Res 2003; 63: 493644.
  • 31
    McKeehan WL,Wang F,Kan M. The heparan sulfate-fibroblast growth factor family: diversity of structure and function. Prog Nucleic Acid Res Mol Biol 1998; 59: 13576.
  • 32
    Feng S,Wang F,Matsubara A,Kan M,McKeehan WL. Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells. Canc Res 1997; 57: 536978.
  • 33
    Foster BA,Gingrich JR,Kwon ED,Madias C,Greenberg NM. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Canc Res 1997; 57: 332530.
  • 34
    Brizuela L,Draetta G,Beach D. p13suc1 acts in the fission yeast cell division cycle as a component of the p34cdc2 protein kinase. EMBO J 1987; 6: 350714.
  • 35
    Bloom J,Pagano M. Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin Canc Biol 2003; 13: 417.
  • 36
    Philipp-Staheli J,Payne SR,Kemp CJ. p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp Cell Res 2001; 264: 14868.
  • 37
    Daniel C,Pippin J,Shankland SJ,Hugo C. The rapamycin derivative RAD inhibits mesangial cell migration through the CDK-inhibitor p27KIP1. Lab Invest 2004; 84: 58896.
  • 38
    Itoh Y,Masuyama N,Nakayama K,Nakayama KI,Gotoh Y. The cyclin-dependent kinase inhibitors p57 and p27 regulate neuronal migration in the developing mouse neocortex. J Biol Chem 2007; 282: 3906.
  • 39
    Li Z,Jiao X,Wang C,Ju X,Lu Y,Yuan L,Lisanti MP,Katiyar S,Pestell RG. Cyclin D1 induction of cellular migration requires p27(KIP1). Canc Res 2006; 66: 998694.
  • 40
    Nguyen L,Besson A,Heng JI,Schuurmans C,Teboul L,Parras C,Philpott A,Roberts JM,Guillemot F. p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex. Genes Dev 2006; 20: 151124.
  • 41
    Kawauchi T,Chihama K,Nabeshima Y,Hoshino M. Cdk5 phosphorylates and stabilizes p27kip1 contributing to actin organization and cortical neuronal migration. Nat Cell Biol 2006; 8: 1726.
  • 42
    Besson A,Gurian-West M,Schmidt A,Hall A,Roberts JM. p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 2004; 18: 86276.
  • 43
    Condeelis J,Segall JE. Intravital imaging of cell movement in tumours. Nat Rev Canc 2003; 3: 92130.
  • 44
    Baldassarre G,Belletti B,Nicoloso MS,Schiappacassi M,Vecchione A,Spessotto P,Morrione A,Canzonieri V,Colombatti A. p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. Canc Cell 2005; 7: 5163.
  • 45
    Galardi S,Mercatelli N,Giorda E,Massalini S,Frajese GV,Ciafre SA,Farace MG. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 2007; 282: 2371624.